Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Codexis (CDXS)

Codexis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDXS
DateTimeSourceHeadlineSymbolCompany
16/01/202523:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
16/01/202522:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
16/01/202521:05GlobeNewswire Inc.Codexis Appoints Christos Richards to Board of DirectorsNASDAQ:CDXSCodexis Inc
10/01/202521:05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
02/01/202521:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/12/202421:05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
19/11/202421:05GlobeNewswire Inc.Codexis to Participate in Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CDXSCodexis Inc
14/11/202421:53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDXSCodexis Inc
14/11/202421:05GlobeNewswire Inc.Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi TherapeuticsNASDAQ:CDXSCodexis Inc
12/11/202421:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
12/11/202421:05GlobeNewswire Inc.Codexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNASDAQ:CDXSCodexis Inc
12/11/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
11/11/202421:05GlobeNewswire Inc.Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi TherapeuticsNASDAQ:CDXSCodexis Inc
08/11/202421:05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
04/11/202421:05GlobeNewswire Inc.Codexis to Participate in Upcoming Healthcare ConferencesNASDAQ:CDXSCodexis Inc
31/10/202420:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDXSCodexis Inc
31/10/202420:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
31/10/202420:05GlobeNewswire Inc.Codexis Reports Third Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
28/10/202420:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
24/10/202420:05GlobeNewswire Inc.Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual MeetingNASDAQ:CDXSCodexis Inc
22/10/202420:05GlobeNewswire Inc.Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of DirectorsNASDAQ:CDXSCodexis Inc
22/10/202420:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
14/10/202411:05GlobeNewswire Inc.Codexis Announces New Employment Inducement GrantsNASDAQ:CDXSCodexis Inc
10/10/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
10/10/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
10/10/202422:19Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
10/10/202420:05GlobeNewswire Inc.Codexis to Report Third Quarter 2024 Financial Results on October 31NASDAQ:CDXSCodexis Inc
02/10/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/10/202420:05GlobeNewswire Inc.Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of CompanyNASDAQ:CDXSCodexis Inc
01/10/202411:05GlobeNewswire Inc.Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciencesNASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS